We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,562

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTLP
8976
PUT
DELISTED
Cantaloupe
CTLP
$299K ﹤0.01%
37,600
-28,500
-43% -$185K
UTL icon
8977
CALL
Unitil
UTL
$986M
$299K ﹤0.01%
5,900
-1,100
-16% -$61K
UYM icon
8978
PUT
ProShares Ultra Materials
UYM
$40M
$299K ﹤0.01%
12,400
+3,900
+46% +$86.9K
ONT
8979
CALL
Onterris Inc
ONT
$565M
$299K ﹤0.01%
7,100
-48,800
-87% -$1.75M
ATNM icon
8980
CALL
Actinium Pharmaceuticals
ATNM
$33.9M
$299K ﹤0.01%
40,300
+3,300
+9% +$28.1K
BSCR icon
8981
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4.6B
$299K ﹤0.01%
+15,715
New +$302K
NHI icon
8982
PUT
National Health Investors
NHI
$3.61B
$299K ﹤0.01%
5,700
-7,500
-57% -$386K
BBVA icon
8983
CALL
Banco Bilbao Vizcaya Argentaria
BBVA
$159B
$299K ﹤0.01%
38,900
-30,100
-44% -$215K
ALT icon
8984
PUT
Altimmune
ALT
$578M
$299K ﹤0.01%
84,600
-181,900
-68% -$817K
EVBG
8985
CALL
DELISTED
Everbridge, Inc. Common Stock
EVBG
$299K ﹤0.01%
11,100
+5,300
+91% +$143K
QUAD icon
8986
CALL
Quad
QUAD
$522M
$299K ﹤0.01%
79,400
-3,700
-4% -$13.4K
AROC icon
8987
CALL
Archrock
AROC
$5.98B
$298K ﹤0.01%
29,100
-17,300
-37% -$171K
BGI icon
8988
Birks Group
BGI
$7.17M
$298K ﹤0.01%
56,265
-132,330
-70% -$1.03M
LOCO icon
8989
PUT
El Pollo Loco
LOCO
$471M
$298K ﹤0.01%
34,000
-21,100
-38% -$198K
GOOD
8990
CALL
Gladstone Commercial Corp
GOOD
$622M
$298K ﹤0.01%
24,100
-200
-0.8% -$2.4K
ETD icon
8991
Ethan Allen Interiors
ETD
$569M
$298K ﹤0.01%
10,537
-141,837
-93% -$3.85M
RLJ icon
8992
CALL
RLJ Lodging Trust
RLJ
$1.69B
$298K ﹤0.01%
29,000
-1,200
-4% -$12.5K
EOSE icon
8993
Eos Energy Enterprises
EOSE
$1.34B
$297K ﹤0.01%
68,515
-367,433
-84% -$964K
REPL icon
8994
CALL
Replimune Group
REPL
$1.47B
$297K ﹤0.01%
12,800
+5,900
+86% +$115K
BALY icon
8995
PUT
Bally's
BALY
$450M
$297K ﹤0.01%
19,100
+3,800
+25% +$61.3K
FC icon
8996
PUT
Franklin Covey
FC
$215M
$297K ﹤0.01%
6,800
-4,100
-38% -$152K
PTCT icon
8997
PUT
PTC Therapeutics
PTCT
$6.06B
$297K ﹤0.01%
7,300
-18,700
-72% -$915K
FINS
8998
Angel Oak Financial Strategies Income Term Trust
FINS
$421M
$297K ﹤0.01%
+25,115
New +$301K
CCBG icon
8999
Capital City Bank Group
CCBG
$889M
$296K ﹤0.01%
9,669
-13,007
-57% -$393K
LE icon
9000
Lands' End
LE
$379M
$296K ﹤0.01%
38,158
-86,187
-69% -$696K

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.